INTERNATIONAL PATENT: ALTRUBIO INC. FILES APPLICATION FOR "METHODS OF USING TETRAVALENT ANTI-PSGL-1 ANTIBODIES TO TREAT ULCERATIVE COLITIS"

GENEVA, April 21 -- ALTRUBIO INC. (1209 Orange StreetWilmington, Delaware 19801) filed a patent application (PCT/US2024/051082) for "METHODS OF USING TETRAVALENT ANTI-PSGL-1 ANTIBODIES TO TREAT ULCERATIVE COLITIS" on Oct 11, 2024. With publication no. WO/2025/081065, the details related to the patent application was published on Apr 17, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HALL, Jesse W. (2908 Woodford DriveLa Jolla, California 92037)

Abstract: Provided herein are methods for treating ulcerative colitis (e.g., moderately to several active ulcerative colitis and/or ulcerative co...